---
title: "BOYA BIOLOGY has continuously received a Wind ESG A rating, with a comprehensive score of 7.16"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288149167.md"
description: "On May 29, 2026, BOYA BIOLOGY maintained an A rating in the Wind ESG rating, with a comprehensive score of 7.16, higher than the industry average. It ranked 42nd in the biotechnology III sector. Despite outstanding performance in the environmental dimension, the decline in scores for social and governance dimensions led to a slight decrease in the overall score. The company has a comprehensive system for waste management, energy utilization, and climate change response, but there is still room for improvement in certain information disclosures"
datetime: "2026-05-30T15:02:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288149167.md)
  - [en](https://longbridge.com/en/news/288149167.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288149167.md)
---

# BOYA BIOLOGY has continuously received a Wind ESG A rating, with a comprehensive score of 7.16

According to Tongbi Finance, on May 29, 2026, China Resources BOYA Biology Pharmaceutical Group Co., Ltd. (stock abbreviation: BOYA Biology, code: 300294.SZ) received a Wind ESG rating of A, unchanged from the previous period. The company's overall score is 7.16, higher than the biotechnology III industry average of 6.38. It ranks 42nd among 151 companies in the biotechnology III industry, placing it in the top 27.81% of the industry. The scores for the environmental, social, and governance dimensions are 5.41, 5.84, and 6.39, respectively.

Compared to the previous rating, the overall score decreased from 7.53 to 7.16, a decline of 0.37 points. The contribution from management practices dropped from 4.54 to 4.17, a decrease of 0.37 points. The contribution from controversy events remained stable at 2.99. By dimension, the environmental score increased by 0.53 points, while the social score decreased by 0.45 points, and the governance score fell by 1.13 points.

## Rating Observation

In the environmental dimension, the company demonstrated comprehensive management and practical capabilities, covering various areas such as waste management, energy management, and climate change response. The company has obtained ISO 14001 and ISO 50001 certifications and has revised and implemented several environmental management systems, including the "Energy Conservation and Ecological Environment Protection Supervision and Management Measures." In terms of waste management, the total amount of non-hazardous waste in 2025 is 42.08 tons, and the total amount of hazardous waste is 69.95 tons. The company has improved management levels through measures such as classified collection, resource utilization, and compliant disposal. In energy management, the company has deployed a photovoltaic system with a total capacity of 2,581.76 kilowatts peak, providing green electricity for smart factories and reducing energy consumption per batch of products by over 30% through the transformation of magnetic levitation refrigeration units. In response to climate change, the company's total greenhouse gas emissions (Scope 1 and Scope 2) amount to 33,329.13 tons of carbon dioxide equivalent, and it has implemented distributed photovoltaic power generation and energy storage systems in line with the "dual carbon" goals to enhance energy-saving benefits. However, there is still room for improvement in the disclosure of recycling rates and target setting information in the areas of waste and energy management.

In the social dimension, the company has demonstrated strong organizational capabilities in product quality management and R&D innovation, while also actively practicing employee care and hiring. The company has passed the QES management system recertification and achieved comprehensive coverage of an end-to-end digital quality traceability system to ensure quality management throughout the product lifecycle. R&D investment accounts for 4.71% of revenue, with R&D staff making up 10.1%, and it has one national-level R&D platform, two provincial and ministerial-level R&D platforms, and one postdoctoral workstation to support technological breakthroughs. In the employment sector, the company safeguards employee rights through the "Recruitment and Allocation Management System" and has invested a total of 793,700 yuan in employee care, achieving a 93% employee satisfaction rate in 2025. However, information disclosure in the supply chain area is relatively limited, particularly regarding the proportion of sustainably certified suppliers and labor protection, indicating further room for improvement In terms of governance, the company has demonstrated certain checks and balances in the structure of the board of directors and audit independence, but there are still limitations in diversity performance. The proportion of independent directors on the board is 36.36%, and there are no independent directors with a tenure exceeding 6 years. The CEO does not concurrently serve as the chairman, reflecting a certain level of governance checks and balances. The attendance rate of board members reached 100%, and the proportion of independent directors on the audit committee is 66.67%, with the chairman being an independent non-executive director, further strengthening audit independence. However, the proportion of female executives is 0%, reflecting a lack of gender diversity. In addition, information regarding the anti-corruption management system and certification has not yet been extracted for disclosure and requires further observation.

Content generated by AI on May 29, 2026, please verify important information

### Related Stocks

- [300294.CN](https://longbridge.com/en/quote/300294.CN.md)

## Related News & Research

- [07:09 ET50 Years of Vinamilk: Vietnam Recognizes Anniversary with Second Labor Hero Title](https://longbridge.com/en/news/294352276.md)
- [REG - Trium Capital LLP Pinewood Tech Gp PLC - Form 8.3 - Pinewood_Technologies](https://longbridge.com/en/news/294080296.md)
- [FDA Grants License To First-Ever Freeze-Dried Plasma Product In US](https://longbridge.com/en/news/294355452.md)
- [Wesizwe Platinum suspends Bakubung mine operations after union-led employee gatherings raise safety risks](https://longbridge.com/en/news/294524307.md)
- [Shenzhen GTJA co-leads Changyu Pharma’s CNY 250 million Series D financing round](https://longbridge.com/en/news/294028268.md)